Australia - inglés - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - azithromycin, quantity: 600 mg - tablet, film coated - excipient ingredients: calcium hydrogen phosphate; pregelatinised maize starch; croscarmellose sodium; sodium lauryl sulfate; magnesium stearate; titanium dioxide; purified talc; xanthan gum; polyvinyl alcohol; lecithin - azithromycin is indicated for the treatment of infections of mild to moderate severity in adults: 1. lower respiratory tract infections: acute bacterial bronchitis due to streptococcus pneumoniae, haemophilus influenzae or moraxella catarrhalis. community acquired pneumonia due to streptococcus pneumoniae or haemophilus influenzae in patients suitable for outpatient oral treatment. 2. upper respiratory tract infections: acute sinusitis due to streptococcus pneumoniae or haemophilus influenzae. acute streptococcal pharyngitis. note: penicillin is the usual drug of choice in the treatment of streptococcus pyogenes pharyngitis, including the prophylaxis of rheumatic fever. azithromycin appears to be almost as effective in the treatment of streptococcal pharyngitis. however, substantial data establishing the efficacy of azithromycin in the subsequent prevention of rheumatic fever are not available at present. 3. uncomplicated skin and skin structure infections: uncomplicated infections due to staphlococcus aureus, streptococcus pyogenes or streptococcus agalactiae. abscesses usually require surgical drainage. 4. sexually transmitted diseases: uncomplicated urethritis and cervicitis due to chlamydia trachomatis. note: at the recommended dose azithromycin cannot be relied upon to treat gonorrhoea or syphilis. as with other drugs for the treatment of non-gonococcal infections, it may mask or delay the symptoms of incubating gonorrhoea or syphilis. appropriate tests should be performed for the detection of gonorrhoea or syphilis and treatment should be instituted as required. 5. azithromycin is also indicated for the treatment of chlamydia trachomatis conjunctivitis and trachoma. 6. azithromycin is also indicated for the prevention of infection due to mycobacterium avium-intracellulare complex (mac) disease, when used as the sole agent or in combination with rifabutin at its approved dose, in adults and children aged more than 12 years with hiv infection and cd4 cell count less than or equal to 75 cells/microl (see precautions). disseminated infection due to mycobacterium avium-intracellulare complex should be excluded by a negative blood culture prior to commencement of therapy.

Australia - inglés - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - azithromycin -

Reino Unido - inglés - MHRA (Medicines & Healthcare Products Regulatory Agency)

merck sharp & dohme ltd - posaconazole - oral suspension - 40mg/1ml

Reino Unido - inglés - MHRA (Medicines & Healthcare Products Regulatory Agency)

merck sharp & dohme ltd - posaconazole - gastro-resistant tablet - 100mg

Reino Unido - inglés - MHRA (Medicines & Healthcare Products Regulatory Agency)

merck sharp & dohme ltd - posaconazole - solution for infusion - 18mg/1ml

Irlanda - inglés - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd., t/a gerard laboratories - posaconazole - gastro-resistant tablet - 100 milligram(s) - triazole derivatives; posaconazole

Australia - inglés - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme australia pty ltd - posaconazole -

Australia - inglés - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - indapamide hemihydrate; perindopril erbumine -

Israel - inglés - Ministry of Health

cts chemical industries ltd, israel - nifedipine - tablets prolonged release - nifedipine 60 mg - nifedipine - nifedipine - chronic stable angina, hypertension.

Israel - inglés - Ministry of Health

cts chemical industries ltd, israel - nifedipine - tablets prolonged release - nifedipine 30 mg - nifedipine - nifedipine - chronic stable angina, hypertension.